CDC and ACIP update recommended immunization schedule for US children and adolescents

The Centers for Disease Control and Prevention (CDC) and the Advisory Committee on Immunization Practices (ACIP) have released an update to the recommended immunization schedule for children and adolescents aged 18 years or younger in the United States. This is a publication categorized as 'OTHER', and it represents official public health guidance rather than a primary research study. The specific changes to the schedule, the intervention or exposure being evaluated, and any comparator schedules are not reported in the provided data.

No primary or secondary outcomes, main results, effect sizes, or statistical measures are reported, as this appears to be a summary of policy recommendations. Similarly, no data on safety, adverse events, serious adverse events, discontinuations, or tolerability from a formal study are provided. The follow-up duration and sample size are also not reported.

Key limitations include the absence of reported study methodology, results data, and funding or conflict of interest disclosures. The practice relevance is not explicitly stated, but the document serves as the authoritative source for current immunization recommendations. Clinicians should rely on the complete, official schedule documents from the CDC and ACIP for detailed guidance on vaccine types, timing, and indications for this population.